Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Oculus Receives China OK for Animal Wound Product

publication date: Nov 16, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Oculus Innovative Sciences of California reported that its partners have received China regulatory approval to market its wound healing solution as an animal product. Based on the company’s Microcyn® technology, Vetericyn™ products speed the healing of wounds while fighting infection. Bayer Animal Health secured the approvals in China and Taiwan. More details...

Stock Symbol: (NSDQ: OCLS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors